On examination she was emaciated and bedridden. Her height was 147cm and weight 32kg. The clinical findings were (1) bronchial asthma that preceded the developmental symptoms, (2) some eruptions like purpura seen in the lateral side of the left leg. However, A. dorsalis pedis was palpable bilaterally, and (3) muscular atrophy and weakness in both upper and lower extremities with distal dominant distribution. The patellar and Achilles tendon reflexes were negative bilaterally. The grip strength was 0.5kg on the right side, and 6kg on the left side. A skin biopsy was performed from the lateral side of the left leg, at approximately 14 months after the onset of neuropathy.
The result showed necrosis in the vessels, and the elastic lamina was disrupted and surrounded by infiltration of a large number of neutrocytes and lymphocytes in the perivascular tissues (Fig. 1 ). There were small numbers of eosinophils in few regions of tissue (Fig. 2) .
Diagnosis of AGA was made clinically and pathologically, 30mg of prednisolone per day was administered from June 6, however, the ischemic areas had by then developed into both legs and the right first to third toes were necrosed (Fig. 3) . The amount of prednisolone was gradually decreased within about a two-month period to 10mg of prednisolone because of gastritis. On September 19, 1991, the necrosed region spread to the right Achilles tendon area and both calcaneal areas, requiring amputation below the knee on the right side and at the Chopart's joint on the left side. There have been 54 case reports in Japan during the two years from January 1993 (Shibata et al.) to December 1994 (Katsuki et al.), involving 22 men and 32 women, whose ages ranged from 13 to 77 years, averaging 45 years (excluding one case of 4-year-old boy who did not suffer from bronchial asthma (Hatakeyama et al. 1994) ). The mean duration of asthma prior to onset of vasculitis was 3.3 years in the series of 11 cases reported by Hayakawa et al. in 1993. Heart failure, myocardial infarction and cerebral hemorrhage were the three major causes of death in 7 cases that were fatal.
Mononeuritis multiplex in peripheral spinal nerves manifesting as the main clinical sign in two (Sameda et al. 1993; Tsuda et al. 1994 ) of the 54 cases, and one (Sameda et al. 1993 ) of these had a drop foot.
A neurological disorder is usually the cause of mononeuritis multiplex (Chumbley et al. 1977; Lanham et al. 1984; Sehgel et al. 1995) which frequently develops in the peripheral spinal nerves (Lanham et al. 1984) . Sensory disturbance then occurs in the sural nerve in the early stages. Inoue et al. (1992) have analysed 8 cases with peripheral nerve involvement.
Six of these 8 cases had a sensory disturbance in the sural nerve region. In 7 of these 8 cases, a sural nerve biopsy showed infiltration by mononuclear cells into the endoneurium and perineurium, with granulomatous lesions in the perineurium, but no eosinophils. Kawai et al. (1977) have reported that a left ulnar nerve lesion in the axilla, due to AGA, was misdiagnosed as a tumor of the ulnar nerve in the epineurium. During resection, numerous yellow granules 1-2 mm in diameter were seen on the epineurium.
Drop foot and weakness in the foot usually develops in the later stages due to the peroneal nerve involvement, and has been described by several authors (Dorfman et al. 1983; Cavallaro et al. 1988; Engelhardt et al. 1989; Marazzi et al. 1992; Scully et al. 1992; Sameda et al. 1993) . Cavallaro et al. (1988) described a sural nerve biopsy in the late stage involving drop foot, which found an almost complete disappearance of myelinated fibers and an involvement of unmyelinated fibers. A skin biopsy showed small granuloma with histiocytic infiltration. In our case, a skin biopsy was conducted during the late chronic necrotizing stage, and showed necrosis and disruption of the vessels with infiltration of neutrocytes and lymphocytes into adjacent tissue.
In the early stages, AGA responds well steroid treatment. Patients presenting drop foot treated with 40-to-60mg prednisolone or prednisone per day generally show improvement or stabilization (Dorfman et al. 1983; Marazzi et al. 1992; Sameda et al. 1993 ). According to the guidelines for AGA advocated by the Ministry of Health and Welfare in Japan (Yoshida, 1992) , the initial dosage of 20-to-80mg prednisolone should be maintained for 2 to 4 weeks, and then Marrazi et al. (1992) described that in one of three cases, neuropathy in the lower limbs and other signs and symptoms vanished within 10 days of treatment with 50mg prednisone, but that 50mg steroid therapy was withdrawn after 60 days because of hemorrhaging gastritis. All symptoms and signs reappeared one month later. Three months later, the patient was unable to walk without support. In our case, the reduction of steroid therapy led to the recurrence of bronchial asthma and subsequently to heart failure. Engelhardt et al. (1989) reported that in one case of drop foot, 80 mg prednisolone and 100mg azathiopirine was administered, and the amount of prednisolone was decreased slowly down to 12mg by controlling erythrocyte sedimentation rate (ESR). This 12mg was maintained and the patient's general condition improved, with only slight paresis remaining at one year and 10 months after beginning of the treatment. However, marked osteoporosis in the spinal column with pain occurred at 2 years of steroid therapy.
Peripheral neuropathy showed gradual improvement, and the patient eventually recovered to be able to walk independently in one of Dorfman's (1983) 
